Laevo-dopa for Parkinsonism.
D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D014268:Trifluoperazine / Q000627:therapeutic use
D014268:Trifluoperazine; D004295:Dihydroxyphenylalanine; D006220:Haloperidol